To answer the question whether the elevation of LDL-cholesterol in IDDM patients with incipient and established diabetic nephropathy is accompanied by changes in LDL size or composition, we studied distribution of LDL particles in 57 normoalbuminuric gg/min, median and range], in 46 microalbuminuric btg/min] and in 33 proteinuric [AER 422 (233-1756)btg/min] IDDM patients as well as in 49 non-diabetic control subjects with normoalbuminuria. The three diabetic groups were matched for duration of diabetes and glycaemic control. The mean particle diameter of the major LDL peak was determined by nondenaturing gradient gel electrophoresis. Composition and density distribution of LDL were determined in the subgroups of each patient group by density gradient ultracentrifugation. Normoalbuminuric IDDM patients had larger L DL particles than non-diabetic control subjects (260 A vs 254 A, p < 0.05). LDL particle diameter was inversely correlated with serum triglycerides in all groups (p < 0.05 for normoalbuminuric andp < 0.001 for other groups). Triglyceride content of LDL was higher in three IDDM groups compared to control group (p < 0.05). The elevation of LDL mass in microalbuminuric and proteinuric IDDM groups compared to normoalbuminuric IDDM group (p < 0.05 for both) was mainly due to the increment of light LDL (density 1.0212-1.0343 g/ml). There were no significant changes in the density distribution or composition of LDL between the three diabetic groups. In conclusion the increase of LDL mass without major compositional changes suggests that the elevation of LDL in incipient and established diabetic nephropathy is primarily due to the increased number of LDL particles. The prevalence of atherogenic small dense LDL particles in IDDM patients with microalbuminuria and proteinuria is closely dependent on plasma triglyceride concentration. [Diabetologia (1994) 37: 681q588] Key words IDDM, diabetic nephropathy, microalbuminuria, proteinuria, lipid metabolism, small dense LDL Cardiovascular disease is the major cause of excess morbidity and mortality among IDDM patients [1] [2] [3] [4] . In particular the patients with diabetic nephropathy are at high risk of cardiovascular disease and have a relative Abbreviations: AER, urinary album excretion rate; CETR cholesteryl ester transfer protein; IDDM, insulin-dependent diabetes mellitus; CHD, coronary heart disease; ApoB, apolipoprotein B. mortality 30-times higher than patients without nephropathy [5, 6] . Recently, microalbuminuria per se has been recognized as a risk marker for CHD mortality in both NIDDM and non-diabetic populations [7] [8] . In IDDM patients microalbuminuria predicts the development of clinical proteinuria but so far the impact of microalbuminuria on CHD mortality in IDDM has been evaluated only in small groups [9] . The link between dyslipidaemias and diabetic nephropathy is commonly recognized, and lipid abnormalities may contribute to the excess CHD risk although the quantitative and differential impact of the several risk factors present in these patients is not established. Several studies have reported elevations of serum total and LDL cholesterol, trigly-
Summary
To answer the question whether the elevation of LDL-cholesterol in IDDM patients with incipient and established diabetic nephropathy is accompanied by changes in LDL size or composition, we studied distribution of LDL particles in 57 normoalbuminuric [AER 7 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) gg/min, median and range], in 46 microalbuminuric [AER 50 btg/min] and in 33 proteinuric [AER 422 (233-1756)btg/min] IDDM patients as well as in 49 non-diabetic control subjects with normoalbuminuria. The three diabetic groups were matched for duration of diabetes and glycaemic control. The mean particle diameter of the major LDL peak was determined by nondenaturing gradient gel electrophoresis. Composition and density distribution of LDL were determined in the subgroups of each patient group by density gradient ultracentrifugation. Normoalbuminuric IDDM patients had larger L DL particles than non-diabetic control subjects (260 A vs 254 A, p < 0.05). LDL particle diameter was inversely correlated with serum triglycerides in all groups (p < 0.05 for normoalbuminuric andp < 0.001 for other groups). Triglyceride content of LDL was higher in three IDDM groups compared to control group (p < 0.05). The elevation of LDL mass in microalbuminuric and proteinuric IDDM groups compared to normoalbuminuric IDDM group (p < 0.05 for both) was mainly due to the increment of light LDL (density 1.0212-1.0343 g/ml). There were no significant changes in the density distribution or composition of LDL between the three diabetic groups. In conclusion the increase of LDL mass without major compositional changes suggests that the elevation of LDL in incipient and established diabetic nephropathy is primarily due to the increased number of LDL particles. The prevalence of atherogenic small dense LDL particles in IDDM patients with microalbuminuria and proteinuria is closely dependent on plasma triglyceride concentration. [Diabetologia (1994) 37 : 681q588] mortality 30-times higher than patients without nephropathy [5, 6] . Recently, microalbuminuria per se has been recognized as a risk marker for CHD mortality in both NIDDM and non-diabetic populations [7] [8] . In IDDM patients microalbuminuria predicts the development of clinical proteinuria but so far the impact of microalbuminuria on CHD mortality in IDDM has been evaluated only in small groups [9] . The link between dyslipidaemias and diabetic nephropathy is commonly recognized, and lipid abnormalities may contribute to the excess CHD risk although the quantitative and differential impact of the several risk factors present in these patients is not established. Several studies have reported elevations of serum total and LDL cholesterol, trigly- [10] [11] [12] [13] . Whether the changes of lipids and lipoproteins correlate with the degree of albuminuria remains however uncertain [10, 12, 14] . So far much of the attention has been focused on the concentrations of serum lipids and lipoproteins neglecting the heterogeneity of lipoprotein particles. LDL consists of a spectrum of particles which vary in their size, density, composition and possibly atherogeneity. Two distinct LDL subclass phenotypes can be distinguished according to LDL particle size distribution separated by gradient gel electrophoresis [15] . Pattern A consists of a major LDL peak with LDL particle diameter greater than 255 A and of minor peak with smaller particle size [15] . In pattern B the diameter of the major LDL peak is equal to or less than 255 A [15] . A predominance of the small, dense LDL particles which occurs in pattern B is considered to be highly atherogenic [15] [16] [17] . Growing evidence indicates that serum triglyceride concentration is one important determinant of structural properties of LDL [18] [19] [20] [21] . Several studies have reported that decrease of LDL particle size, increased density and abnormal composition of LDL are associated with elevated VLDL concentrations [18] [19] [20] [21] [22] [23] . As this could be a feature in the dyslipidaemia of IDDM patients with kidney disease we investigated in the present study the LDL particle size, density distribution and composition in IDDM patients with incipient and established diabetic nephropathy across a large spectrum of AER.
Subjects and methods

Patients
This study included a subpopulation of 136 subjects with gradient gel electrophoresis available out of a larger study group of IDDM patients (n = 153) who were recruited for a cross-sectional study [ (27 men, 22 women) with normal fasting blood glucose and HbA1 values. All groups were matched for age and BMI values, and the three IDDM groups were matched for duration of diabetes, glycaemic control and insulin dose. All participants had normal renal function and had serum creatinine concentration below 110 gmol/1. None of the participants received lipid lowering medication. None of the normoalbuminuric IDDM patients nor any of the healthy subjects were being treated for hypertension. IDDM patients taking diuretics or betablockers were excluded from the study because these drugs may affect the lipid and lipoprotein metabolism [24] [25] [26] . Three microalbuminuric IDDM patients were on treatment with ACE inhibitors and one with Ca-channel blockers for hypertension. Six proteinuric IDDM patients were being treated with ACE-inhibitors, one with Ca-channel blocker and two were treated with a combination of ACE-inhibitor and Ca-channel blocker. Three normoalbuminuric, three proteinuric and four healthy subjects were taking oral contraceptives. The participants were asked to abstain from alcohol during the preceding 3 days. Ethical permission for the study was obtained from the Ethics Committees at Guy's Hospital, London, UK and the III Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. Clinical characteristics of the subjects are shown in Table 1 .
Lipids and lipoproteins
Blood samples were drawn in the morning after an overnight fast. The serum was separated immediately by centrifugation at 3000 rev/min for 30 min at 4 ~ The fresh serum samples from Guy's Hospital were kept at 4 ~ and arrived at the laboratory in Helsinki within 24 h. Sequential ultracentrifugation was used to isolate serum lipoprotein fractions (VLDL, LDL and HDL) as previously described [27, 28] .
LD L density gradient ultracentrifugation
Because LDL density gradient ultracentrifugation is extremely laborious and tedious it was performed only in a randomly selected subgroup of patients including 12 normoalbuminuric (3 men, 9 women), 15 microalbuminuric (11 men, 4 women), 12 proteinuric IDDM patients (6 men, 6 women), and 13 healthy control subjects (9 men, 4 women). After the isolation of VLDL fraction at a density of 1.006 g/ml the infranate was adjusted directly to the density of 1.0630 g/ml and ultracentrifuged at 35 000 rev/min for 24 h at 2 ~ The fraction containing both IDL and LDL was removed by tube slicing and dialysed for 8 h against NaBr solution with a density of 1.0340 g/ml. The LDL density gradient ultracentrifugation was performed according to the method previously described by Shen et al. [29] with slight modifications. The discontinuous gradient was prepared with NaBr solutions into Beckman Ultraclear 9/16 x 33/14 13-ml centrifuge tubes (Beckman Inc., Palo Alto, Calif., USA) and the densities of the sample tubes were controlled directly as previously described [30] . Ultracentrifugation was carried out in a Beckman L8-70 ultracentrifuge with an SW 40TI swinging bucket rotor [(Cat. No 331302) Beckman Inc.], 26 fractions of 0.5 ml were collected. The four lightest fractions within density 1.0181 to 1.0202 g/ml contained IDL and were discarded. The concentrations of cholesterol, free cholesterol, triglycerides, phospholipids and apoB were measured in the remaining 22 fractions (density = 1.0212-1.0650 g/ml). The LD L mass in each fraction was calculated by adding together the concentrations of different LDL components. The 11fractions having mean densities from 1.0212 to 1.0343 g/ml were designated light LDL and the 11 fractions with mean densities from 1.0360 to 1.0650 g/ml were designated as dense LDL. The LDL peak density is defined as the density of the fraction with the greatest LDL mass.
LDL gradient gel electrophoresis
Nondenaturing polyacrylamide gradient gel electrophoresis of LDL was performed from frozen serum samples using commercial Pharmacia 2/16 gels (Pharmacia, Uppsala, Sweden) as previously described [31] . The gels were stained with Sudan Black B lipid stain. After the destaining procedure the gels were scanned at 595 nm with a computer assisted scanning densitometer (Cliniscan 2; Helena Laboratories, Beaumont, Texas, USA). The mean particle diameter of the main LDL peak was determined by computer performed comparison of the mobility of the sample with that of a calibrated reference LDL preparation run on each gel. Coefficients of variation for intergel and intragel precisions of the used control sample were 1.22 % and 0.98 %, respectively.
Laboratory analysis
The concentration of cholesterol in serum, VLDL, LDL, HDL and LDL fractions and that of triglycerides in serum, VLDL and LDL fractions were determined by an enzymatic colorimetric assay (F Hoffmann La Roche and Co Ltd. Diagnostica, Basle, Switzerland) using an automatic analyser (Cobas Mira, F Hoffmann La Roche and Co Ltd. Diagnostica). The commercial kits were also used to measure the concentrations of free cholesterol (Boehringer Mannheim GmbH, Diagnostica, Mannheim, Germany) and phospholipids (Wako Chemicals, Neuss, Germany) in the LDL fractions isolated by density gradient ultracentrifugation. The concentration of cholesteryl esters was calculated by subtracting the free cholesterol concentration from the total cholesterol concentration. Immunoturbidometric assay (Orion Diagnostica, Espoo, Finland) was used to measure the concentration of apoB in the serum and LDL fractions. Blood glucose concentration was determined by the glucose oxidase method (Auto-Analyzer; Technicon, Tarrytown, NY, USA). Glycosylated haemoglobin (HbA1) measurement was carried out by microcolumn chromatography (Isolab, Akron, OH, USA) in Helsinki [32] and by the use of electroendosmosis (Coming Chemical, Palo Alto, Calif., USA) in London. The urine albumin concentration was determined by radioimmunoassay [33] .
Statistical analysis
Analysis of data distribution and comparisons between the groups were performed with BMDP statistical software (University of California Press, 1988) for detailed data description (program 2D) and Kruskall-Wallis analysis of variance (3S).
If the Kruskall-Wallis analysis of variance reached statistical significance between four groups, the significances of differences between two groups were assessed with Mann-Whitney nonparametric test (3S). The relationships between the logarithmically transformed variables were estimated with Pearson correlation coefficients. Stepwise regression analysis (2R) was also performed. 
Serum lipids and lipoproteins
Serum total cholesterol concentration was increased in both microalbuminuric and proteinuric IDDM groups by 15 % (p < 0.01 for both), compared to normoalbuminuric IDDM patients (Table 2) . LDL-cholesterol concentration was elevated by 13 % in microalbuminuric and by 14 % in proteinuric IDDM subjects compared to the normoalbuminuric IDDM group (p < 0.01 for both). Note that LDL-cholesterol values in microalbuminuric and proteinuric IDDM groups were similar to the values in the non-diabetic group. Microalbuminuric IDDM patients had 12% lower HDL-cholesterol concentration than normoalbuminuric IDDM subjects (p < 0.05). Concentrations of VLDL-cholesterol, VLDL-triglycerides and apoB did not differ significantly between the four groups ( Table 2 ). Overall female subjects had higher HDL-cholesterol levels than male subjects in each group, but there were no differences in serum total and LDL-cholesterol or apoB concentrations between the sexes (data not shown). Consequently the data from both sexes were pooled for the detailed analyses of LDL.
LD L particle size
Distribution of LDL particle size and the mean particle diameters of the major LDL peak were determined in each subject. The mean particle diameter of the major LDL peak was significantly larger in the normoalbuminuric IDDM group (260 A) than in the control group (254 A) (p < 0.001). The respective diameters of the major LDL peaks were 256 A and 257 A in microalbuminuric and proteinuric IDDM groups ( Density (g/ml) Fig.3 . Density distribution of LDL determined by density gradient ultracentrifugation in normoalbuminuric ( 9 ), microalbuminuric ( O ) and proteinuric ( 9 ) IDDM patients, and in healthy control subjects ( [] ) p < 0.05 in proteinuric andp < 0.001 in control subjects, Fig. 1 ). Note that the range of VLDL-Tg in normoalbuminuric IDDM patients seems to be narrower (range 0.10-0.94 mmol/1) than in control subjects (range 0.07-2.43 mmol/1) if the one outlier with high VLDL-triglycerides (3.51 mmol/1) is excluded. A significant inverse correlation also existed between the mean diameter of the major LDL peak and the logarithm of serum triglycerides in all groups (p < 0.05 for normoalbuminuric IDDM group and p < 0.001 for other groups). A close positive correlation was found between LDL particle diameter and HDL cholesterol concentration in normoalbuminuric IDDM and healthy groups (p < 0.001 for both, Fig. 2) . A similar positive correlation between LDL particle diameter and HDL-cholesterol was observed in microalbuminuric as well as in proteinuric IDDM groups (p < 0.01 and p < 0.05, respectively, Fig.2 ). When stepwise regression analysis was performed, LDL particle diameter was independently associated with serum triglyceride concentration (p < 0.001 for all groups) as well as with HDL-cholesterol concentration (p <0.05 for microalbuminuric IDDM group,p < 0.001 for other groups). 
LDL density
LDL density distribution profiles of the four subgroups are presented in Figure 3 . Although the profiles were similar, LDL peak densities displayed a shift to higher density with increasing albuminuria. In both microalbuminuric and proteinuric IDDM subjects total LDL mass was elevated (p < 0.05 for both) compared to normoalbuminuric IDDM subjects. Examination of LDL subclasses revealed that the absolute increase of LDL mass was mainly due to that of light LDL (Table 3) . Concentration of apoB in the light LDL was increased in microalbuminuric and proteinuric IDDM groups by 40 % and 26 %, respectively, compared to normoalbuminuric IDDM group (p < 0.01 and p < 0.05, respectively, Table 3 ). Also the cholesterol concentration in the light LDL was higher in microalbuminuric and proteinuric IDDM patients than in normoalbuminuric IDDM patients (p < 0.01 and p < 0.05, respectively, Table 3 ). In the control group light LDL represented 72 % (43-87 %) of LDL mass and that of dense LDL only 28 % (13-57 % ). Relative percentages of light and dense LDL subfractions from the total LDL mass did not differ between the four groups (74 % and 26 % in normoalbuminuric, 76% and 24% in microalbuminuric and 74% and 26% in proteinuric IDDM group).
LD L composition
The percentage of cholesterylesters in LDL was decreased but that of triglycerides was increased in normoalbuminuric IDDM patients compared to that of healthy control subjects (p < 0.05 and 0.01, respectively, Table 4 ). The percent content of triglycerides was increased also in microalbuminuric and proteinuric IDDM patients compared to the non-diabetic control group (p < 0.05 for both, Table 4 ). The triglyceride to apoB weight ratio was significantly higher in the three diabetic groups than in the group of healthy control subjects . Cholesteryl esters and free cholesterol to apoB as well as cholesteryl ester to triglyceride weight ratios were similar in all groups (data not shown). Besides triglyceride enrichment in diabetic groups there were no other significant differences in the composition of LDL between the four groups (Table 4) .
Discussion
Dyslipidaemia in our IDDM patients with both microalbuminuria and moderate proteinuria manifested as elevations of serum total and LDL cholesterol concert-trations and lowering of HDL-cholesterol concentration. Our results are consistent with previous observations on serum lipids and lipoproteins in diabetic nephropathy [10] [11] [12] [13] . The fact that the elevations in serum total and VLDL-triglycerides and in apoB concentrations in microalbuminuric and proteinuric IDDM subjects were not as clear as in some other studies probably reflects the fact that proteinuria was moderate in our proteinuric IDDM group. In this study we found that in normoalbuminuric IDDM patients LDL particles were larger and less dense than in non-diabetic control subjects. This change together with lowering of LDL mass can be considered to be anti-atherogenic. In IDDM patients with micro-and macroalbuminuria LDL particle diameters of the major LDL peak were comparable to those in non-diabetic subjects. In this study LDL particle size was closely correlated with serum total and VLDL-triglycerides as well as with HDL-cholesterol concentration. More bouyant LDL in normoalbuminuric IDDM patients is thus explained by concomitant changes of VLDL and HDL as compared to nondiabetic subjects. Overall, our data agree with recent evidence that the prevalence of small dense LDL is related to hypertriglyceridaemia and decrease of HDLcholesterol concentration [22, 34] . It is hypothesized that a high concentration of VLDL-triglycerides causes an increase in CETP-mediated transfer of cholesteryl esters and triglycerides between VLDL and LDL [18] . Triglyceride-enriched LDL serves as a good substrate for hepatic lipase, which hydrolyses LDL-triglycerides resulting in formation of small dense LDL particles [35] . Therefore, the clinical relevance is that hypertriglyceridaemia in IDDM patients with nephropathy could be associated with preponderance of small dense LDL, which is acknowledged to be a risk factor for CHD. The increased atherogeneity of small dense LDL is assumed to be due to its altered catabolism as well as to its increased susceptibility to oxidation [36] [37] [38] [39] . On the other hand, there is growing evidence that the LDL subclass pattern is also genetically determined although the exact magnitude of genetic influence on the variation of LDL size is unclear [40] . Also environmental factors such as diet, exercise and use of/3-adrenergic blockers contribute to alterations of LDL particle size [34, 41, 42] .
Abnormalities in the composition of LDL in normoalbuminuric IDDM patients ie. decreased cholesterylesters and increased triglyceride percent content, are consistent with results reported by James and Pometta [43] . However, the increase of triglycerides in the LDL of IDDM patients was not observed by Bagdade et al. [44] . Chapman et al. [45] have shown that increased density and small particle size of LDL are connected with higher percentage content of apoB, lowered cholesteryl ester content and decreased ratio of lipid to apoB in LDL. In line with this observation the total lipid to protein ratio of LDL tended to be higher S. Lahdenperfi et al.: LDL subclasses in diabetic nephropathy and the LDL peak particle size was larger in our normoalbuminuric diabetic group compared to the nondiabetic control group. In the present study the triglyceride enrichment of LDL persisted also in microalbuminuric and proteinuric IDDM groups. Overall we observed no other compositional changes of LDL between the three diabetic groups. The data is consistent with the study by Winocour et al. [46] who also could not detect any major compositional changes of LDL in nephropathy.
Our data demonstrated an increase of LDL mass in IDDM patients with incipient and established diabetic nephropathy. This increase of LDL occurred primarily in the light LDL which were 48 % and 32 % higher in the microalbuminuric and in the proteinuric IDDM group, respectively, compared to the normoalbuminuric IDDM group. Elevation of dense LDL was less prominent; 18% in the microalbuminuric and 24 % in the proteinuric IDDM group. However, the relative percentages of light and dense LDL from the total LDL mass did not differ significantly between the three diabetic groups. The elevation of apoB in the light LDL suggests that the number of these LDL particles is increased. This is further supported by the fact that no major compositional changes were found in the LDL between the three diabetic groups. Overall, higher numbers of LDL particles in the circulation indicate increased atherogeneity. Why is LDL mass increased in patients with incipient or established diabetic nephropathy? Dullaart et al. [47] have observed an increased cholesterylester transfer activity in IDDM patients with microvascular and macrovascular complications. In these patients the cholesterylester transfer activity correlated positively with serum total, VLDL and LDL cholesterol as well as with apoB concentrations suggesting a role for CETP in the development of dyslipidaemia in these diabetic complications. In line with this we observed an inverse correlation (r = -0.42, p < 0.01) between fasting VLDL triglycerides and esterified cholesterol to triglyceride mass ratio in LDL of our IDDM subjects. Consequently the driving force could be increased cholesterol ester transfer activity. On the other hand Warwick et al. [48] have shown that proteinuria in non-diabetic patients with the nephrotic syndrome is associated with a defect in LDL catabolism via receptor-mediated pathway. When the disease progresses to gross proteinuria there is also oversynthesis of VLDL, which further exacerbates dyslipidaemia and leads to elevation of triglyceride levels [48] . Other studies implicate that the prodcution of LDL apoB is also increased in the nephrotic syndrome [49, 50] . These results may not be directly extrapolated to diabetic nephropathy, and kinetic studies need to be performed in patients with diabetic nephropathy.
In conclusion the data suggest that increase of LDL mass in incipient and established diabetic nephropathy is due to the increased number of LDL particles with-out compositional changes. In the present study the microalbuminuric and proteinuric IDDM patients had only moderate proteinuria and presented no marked alterations of serum triglycerides. Nonetheless, LDL particle size was closely related to serum triglyceride concentration within each group. The recent recognition of the preponderance of small dense LDL within a range of triglyceride values below the therapeutic target values emphasizes the fact that fasting triglycerides should be maintained as low as possible in IDDM patients with diabetic nephropathy and at high risk of CHD.
